SCHEMBL16257547

SCHEMBL16257547

Cc1c(Nc2cccc(C(F)(F)F)c2)ncnc1C(=O)N1CCC(N2CCOCC2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.51
CCR2 P41597 3/20 0.46
EGFR P00533 5/20 0.46
SLC6A2 P23975 1/20 0.46
HTR2A P28223 1/20 0.46
OPRK1 P41145 1/20 0.46
HTR2B P41595 1/20 0.46
SLC6A3 Q01959 1/20 0.46
PDE4D Q08499 1/20 0.46
KCNH2 Q12809 1/20 0.46
BRAF P15056 1/20 0.46
IRAK4 Q9NWZ3 1/20 0.45
PIK3CD O00329 1/20 0.44
PIK3R1 P27986 1/20 0.44
GPR52 Q9Y2T5 1/20 0.44
TP53 P04637 1/20 0.44
GAA P10253 1/20 0.43
CCRL2 O00421 1/20 0.43
POLB P06746 1/20 0.43
SCN9A Q15858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15033677 0.83 CCR2 (0.46) CNR2CCR2EGFRSLC6A2HTR2A
SCHEMBL12180206 0.81 CCR2 (0.74) CCR2EGFRKCNH2
SCHEMBL16257543 0.81 CCR2 (0.74) CCR2EGFRKCNH2
SCHEMBL16257555 0.77 CCR2 (0.56) CCR2EGFRBRAFCCRL2POLB
SCHEMBL10232478 0.77 CCR2 (0.57) CCR2EGFRGPR52
SCHEMBL10232417 0.76 CCR2 (0.63) CCR2CCRL2SCN9ASCN10A
SCHEMBL10178605 0.76 CCR2 (0.48) CCR2GPR52CCRL2SCN9A
SCHEMBL16257525 0.76 CCR2 (0.48) CNR2CCR2EGFRSLC6A2HTR2A
SCHEMBL14306362 0.75 LMNA (0.58) EGFRTP53POLB
SCHEMBL12184078 0.74 CCR2 (0.76) CCR2IRAK4CCRL2SCN9ASCN10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946218-B2 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-02-03 US disclosed
EP-2569295-B1 NEW CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed